Acumen Pharmaceuticals, Inc. (ABOS) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $7.00K; Additional Paid in CapitalUSD $557.19M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-13.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $7.00K; Additional Paid in CapitalUSD $554.65M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $21.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $516.80M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $83.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $514.38M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $109.00K.
Acumen Pharmaceuticals, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $7.00K | $557.19M | $-13.00K | $-499.92M | $57.26M | 3 month · $12.00K | 3 month · $2.52M 6 month · $4.92M | (m) |
| 2026-03-31 | $0.00 | $7.00K | $554.65M | $21.00K | $-467.20M | $87.48M | (m) | 3 month · $2.40M | (m) |
| 2025-12-31 | $0.00 | $6.00K | $516.80M | $83.00K | $-446.46M | $70.43M | (m) | 12 month · $9.85M | (m) |
| 2025-09-30 | $0.00 | $6.00K | $514.38M | $109.00K | $-421.32M | $93.17M | (m) | 3 month · $2.46M 9 month · $7.43M | (m) |
| 2025-06-30 | $0.00 | $6.00K | $511.92M | $23.00K | $-394.87M | $117.08M | (m) | 3 month · $2.50M 6 month · $4.97M | (m) |
| 2025-03-31 | $0.00 | $6.00K | $509.42M | $15.00K | $-353.92M | $155.52M | (m) | 3 month · $2.47M | (m) |
| 2024-12-31 | $0.00 | $6.00K | $506.99M | $-48.00K | $-325.13M | $181.82M | (m) | 12 month · $9.63M | (m) |
| 2024-09-30 | $0.00 | $6.00K | $504.65M | $518.00K | $-287.97M | $217.20M | (m) | 3 month · $2.34M 9 month · $7.29M | (m) |
| 2024-06-30 | $0.00 | $6.00K | $502.31M | $-164.00K | $-258.21M | $243.95M | (m) | 3 month · $2.47M 6 month · $4.95M | (m) |
| 2024-03-31 | $0.00 | $6.00K | $499.84M | $-144.00K | $-237.67M | $262.03M | (m) | 3 month · $2.48M | (m) |
| 2023-12-31 | $0.00 | $6.00K | $489.45M | $312.00K | $-222.80M | $266.97M | (m) | 12 month · $6.14M | 12 month · $1.13M |
| 2023-09-30 | $0.00 | $6.00K | $487.08M | $-509.00K | $-206.30M | $280.27M | (m) | 3 month · $1.60M 9 month · $4.51M | (m) |
| 2023-06-30 | $0.00 | $4.00K | $362.86M | $-646.00K | $-193.34M | $168.87M | (m) | 3 month · $1.52M 6 month · $2.91M | (m) |
| 2023-03-31 | $0.00 | $4.00K | $361.34M | (m) | $-181.73M | $179.09M | (m) | 3 month · $1.39M | (m) |
| 2022-12-31 | $0.00 | $4.00K | $359.95M | $-751.00K | $-170.43M | $188.78M | (m) | 12 month · $3.06M | (m) |
| 2022-09-30 | (m) | $4.00K | $355.17M | (m) | $-157.56M | $196.65M | (m) | 3 month · $840.00K 9 month · $2.17M | (m) |
| 2022-06-30 | (m) | $4.00K | $354.33M | (m) | $-146.85M | $206.52M | (m) | 3 month · $715.00K 6 month · $1.33M | (m) |
| 2022-03-31 | (m) | $4.00K | $353.60M | (m) | $-136.70M | $216.09M | (m) | 3 month · $618.00K | (m) |
| 2021-12-31 | $0.00 | $4.00K | $352.98M | (m) | $-127.57M | $225.18M | (m) | 12 month · $922.00K | (m) |
| 2021-09-30 | (m) | $4.00K | $352.61M | $-28.00K | $-119.22M | $233.36M | (m) | 3 month · $304.00K 9 month · $557.00K | (m) |
| 2021-06-30 | (m) | (m) | $9.24M | (m) | $-115.32M | $-106.08M | (m) | 3 month · $127.00K 6 month · $253.00K | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | $-45.46M | (m) | 3 month · $126.00K | (m) |
| 2020-12-31 | (m) | (m) | $8.37M | (m) | $-26.96M | $-18.59M | (m) | 12 month · $154.00K | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | $-17.87M | (m) | 3 month · $39.00K 9 month · $116.00K | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | $-15.42M | (m) | 3 month · $38.00K 6 month · $77.00K | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $-13.43M | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $-11.42M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |